The liver is a key organ for the clearing of many hormones from the circulatory system (e.g., epidermal growth factor, insulin, vasopressin). In the normal adult rat liver, these hormones do not act as activators of cell growth. During liver regeneration however, when the liver is capable of intense bursts of proliferation, or during the growth of primary hepatocytes in culture, these hormones become potent growth activators. We have focused on the V1 vasopressin receptor system in liver, which upon ligand binding, has been shown to activate the turnover of phosphoinositides. Although much of the work characterizing this turnover has been performed utilizing the V1 system, neither the V1 receptor nor its associated guanine- nucleotide binding proteins (G-proteins) have been isolated. We have recently purified the V1 vasopressin receptor from liver and have begun to characterize and purify the G-proteins associated with this receptor. In addition, we have reconstituted the V1 receptor and associated G-proteins, and have demonstrated that the V1 receptor from liver but not from smooth muscle must be exposed to ligand in order to cause an association of the V1 receptor with G-proteins. Additionally, this results in a change in the V1 receptor from a low affinity state (Kd = 30 nM) to a high affinity state (Kd = 6 nM). We have also observed that a number of other endogenous macromolecules, including gangliosides and phospholipids, have a significant effect on the affinity of the V1 receptor for ligand. We propose to purify the V1-associated G- proteins, study the interaction of the G-proteins with the V1 receptors, and investigate the role of phospholipids, gangliosides, and ions in this interaction. In addition, we propose to produce an antibody directed against the V1 receptor, allowing us to study the turnover and processing of the V1 receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK039328-03
Application #
3239138
Study Section
Cellular Biology and Physiology Subcommittee 1 (CBY)
Project Start
1988-07-01
Project End
1991-02-28
Budget Start
1989-03-01
Budget End
1990-02-28
Support Year
3
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Hoffenberg, S; Shannon, T M; Noonan, T P et al. (1996) Specific and effective interaction of a guanine nucleotide analogue with small G proteins. Mol Pharmacol 49:156-64
Silbiger, S R; Cohen, A J; Fishman, J B et al. (1994) Defective glomerular beta-adrenergic signal transmission in spontaneously diabetic rats. J Lab Clin Med 124:249-54
Johnson, R J; Liu, N G; Fishman, J B et al. (1992) Isolation of a calreticulin-like calcium binding protein from bovine brain. Brain Res Mol Brain Res 12:69-76
Fishman, J B; Rubins, J B; Chen, J C et al. (1991) Modification of brain guanine nucleotide-binding regulatory proteins by tryptamine-4,5-dione, a neurotoxic derivative of serotonin. J Neurochem 56:1851-4
Fishman, J B; Cahill, M; Morin, P et al. (1991) Specific gangliosides increase rapidly in rat liver following partial hepatectomy. Biochem Biophys Res Commun 174:638-46
Elgebaly, S A; Miano, D C; Kreutzer, D L et al. (1990) Cornea derived neutrophil chemotactic factors: intracellular synthesis and release. Curr Eye Res 9:839-45
Volicer, L; Chen, J C; Crino, P B et al. (1989) Neurotoxic properties of a serotonin oxidation product: possible role in Alzheimer's disease. Prog Clin Biol Res 317:453-65
Bielinski, D; McCrory, M; Cahill, M et al. (1988) Differential coupling of smooth muscle and liver vasopressin (V1) receptors to guanine nucleotide binding proteins. Biochem Biophys Res Commun 151:1293-8